All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Therapeutic monitoring of lacosamide, perampanel, and zonisamide during breastfeeding

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F24%3AE0110591" target="_blank" >RIV/00843989:_____/24:E0110591 - isvavai.cz</a>

  • Alternative codes found

    RIV/61988987:17110/24:A2502NYT

  • Result on the web

    <a href="https://www.sciencedirect.com/science/article/pii/S0920121123001894?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S0920121123001894?via%3Dihub</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.eplepsyres.2023.107264" target="_blank" >10.1016/j.eplepsyres.2023.107264</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Therapeutic monitoring of lacosamide, perampanel, and zonisamide during breastfeeding

  • Original language description

    Objective: To provide additional information on the transport of the new anti-seizure medications lacosamide, perampanel, and zonisamide in breast milk and breastfed infants. Methods: Between 2013 and 2022, concentrations of anti-seizure medications were measured in six women with epilepsy (each drug in two patients) using high-performance liquid chromatography. Additionally, concentrations were determined after two consecutive pregnancies in women receiving lacosamide and one woman receiving zonisamide. In all cases, anti-seizure medication concentrations were measured in the maternal serum and breast milk, and five cases, in the infant serum. Results: For lacosamide, the ratios of breast milk/maternal serum concentration varied between 0.77 and 0.93, the ratios of infant/maternal serum concentrations were 0.16 and 0.35, and the ratios of infant serum/milk concentrations were 0.21 and 0.38. For perampanel, the ratios of breast milk/maternal serum concentration were 0.01 and 0.10 and the ratio of infant/maternal serum concentration was 0.36. For zonisamide, the ratios of breast milk/maternal serum concentration varied between 0.76 and 1.26, the ratios of infant/maternal serum concentrations between 0.44 and 0.85, and the ratios of infant serum/milk concentrations between 0.55 and 1.05. Conclusions: Breastfeeding is recommended for women using lacosamide, perampanel, and zonisamide. However, the actual exposure can only be accurately evaluated by determining the serum concentration of anti-seizure medication in breastfed infants.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30104 - Pharmacology and pharmacy

Result continuities

  • Project

  • Continuities

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Others

  • Publication year

    2024

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Epilepsy Research

  • ISSN

    0920-1211

  • e-ISSN

    1872-6844

  • Volume of the periodical

    199

  • Issue of the periodical within the volume

    january

  • Country of publishing house

    NZ - NEW ZEALAND

  • Number of pages

    5

  • Pages from-to

    1-5

  • UT code for WoS article

    001133520200001

  • EID of the result in the Scopus database

    2-s2.0-85179104694